Where does LeMaitre Vascular's cash flow data come from?

Every line is extracted from LeMaitre Vascular's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LeMaitre Vascular LMAT Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$62.4M+8.1%	$57.73M+8.2%	$53.34M+13.2%	$47.12M+4.3%	$45.16M+2.6%
Depreciation and amortization	$10.49M+0.7%	$10.42M+1.8%	$10.23M+1.9%	$10.04M+2.7%	$9.78M+1.8%
Stock-based compensation	$7.87M+0.6%	$7.83M+4.8%	$7.47M+1.8%	$7.34M+4.8%	$7M+6.6%
Deferred income taxes	——	$2.31M+42.6%	$1.62M+74.2%	$930.5K+288%	$239.75K+153%
Amortization of debt issuance costs	——	——	——	——	——
Provision for credit losses	$805K-1.5%	$817K+5.8%	$772K+2.9%	$750K+62.0%	$463K-43.1%
Change in accounts receivable	——	——	——	——	——
Change in accounts payable	——	——	——	——	——
Change in other assets	——	——	——	——	——
Net gains (losses) on investments	——	-$535K-33.3%	-$401.25K-50.0%	-$267.5K-100%	-$133.75K—
Net cash from operating activities	$87.31M+7.5%	$81.25M+10.9%	$73.28M+24.7%	$58.76M+22.2%	$48.09M+9.0%
Capital expenditures	$8.18M+20.6%	$6.78M-3.8%	$7.05M+9.5%	$6.44M-7.7%	$6.98M+0.2%
Acquisitions, net of cash acquired	$1.9M+0.1%	$1.9M+1,899%	$95K0.0%	$95K+116%	$44K—
Purchases of investments	$789.3M+23.1%	$641.33M+114%	$299.64M+4.9%	$285.67M+2.1%	$279.84M+0.7%
Net cash from investing activities	-$73.74M-13.6%	-$64.94M+70.7%	-$222.01M-7.0%	-$207.43M-2.6%	-$202.08M-1.0%
Dividends paid	$19.3M+6.6%	$18.11M+5.5%	$17.17M+5.8%	$16.23M+6.1%	$15.31M+6.5%
Repurchases of common stock	$1.68M-7.7%	$1.82M-7.0%	$1.96M-0.1%	$1.96M-0.2%	$1.96M+14.1%
Proceeds from issuance of common stock	$8.46M+24.0%	$6.82M+15.0%	$5.93M+23.7%	$4.8M+27.3%	$3.77M-41.5%
Other financing activities	——	——	——	——	$1.43M—
Net cash from financing activities	-$12.52M+13.9%	-$14.54M-109%	$153.13M+0.1%	$152.93M+0.1%	$152.82M-3.3%
Effect of exchange rate changes on cash	$518K-43.3%	$914K+522%	$147K—	——	——
Net increase (decrease) in cash	$1.51M-42.6%	$2.63M-41.4%	$4.49M-8.5%	$4.91M+491%	-$1.26M-194%
Income taxes paid	——	——	——	——	——
Amortization expense related to capitalized debt issuance costs	——	——	——	——	——
Increase (Decrease) in Accounts Payable and Other Operating Liabilities	——	——	——	——	——
Increase Decrease In Interest Payable Net	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	——
Inventory write-downs	$2.79M+4.7%	$2.66M-7.3%	$2.87M+0.3%	$2.86M-5.0%	$3.01M-2.6%
Accounts Receivable, Credit Loss Expense (Reversal)	$805K-1.5%	$817K+5.8%	$772K+2.9%	$750K+62.0%	$463K-43.1%
Payments to Acquire Short-Term Investments	$789.3M+23.1%	$641.33M+114%	$299.64M+4.9%	$285.67M+2.1%	$279.84M+0.7%
Payments Of Debt Issuance Costs	——	——	——	——	——
Cash Paid For Operating Lease Liabilities	——	——	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	$518K-43.3%	$914K+522%	$147K—	——	——
Increase Decrease In Inventory And Other Deferred Costs	——	——	——	——	——
Payment For Contingent Consideration Liability Financing Activities	——	——	——	——	$1.43M—
Proceeds From Notes Payable	——	$0-100%	$42.32M-50.0%	$84.63M-33.3%	$126.95M-25.0%
Leased assets obtained in exchange for operating lease liabilities	——	——	——	——	——
Unrealized Gain (Loss) on Investments	——	-$535K-33.3%	-$401.25K-50.0%	-$267.5K-100%	-$133.75K—
Income Taxes Paid, Net	——	——	——	——	——
Free cash flow	$79.12M+6.2%	$74.47M+12.4%	$66.23M+26.6%	$52.32M+27.2%	$41.12M+10.6%
Free cash flow	$79.12M+6.2%	$74.47M+12.4%	$66.23M+26.6%	$52.32M+27.2%	$41.12M+10.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does LeMaitre Vascular's cash flow data come from?: Every line is extracted from LeMaitre Vascular's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.